Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration: A Secondary Analysis of the ASPREE Randomized Clinical Trial.
Robman LD, Wolfe R, Woods RL, Thao LTP, Makeyeva GA, Hodgson LAB, Lepham YA, Jachno K, Phung J, Maguire E, Luong H, Trevaks RE, Ward SA, Fitzgerald SM, Orchard SG, Lacaze P, Storey E, Abhayaratna WP, Nelson MR, Guymer RH, McNeil JJ. Robman LD, et al. Among authors: guymer rh. JAMA Ophthalmol. 2024 May 23:e241584. doi: 10.1001/jamaophthalmol.2024.1584. Online ahead of print. JAMA Ophthalmol. 2024. PMID: 38780931
Gene and cell therapy for age-related macular degeneration: A review.
Trincão-Marques TM, Ayton LN, Hickey DG, Marques-Neves C, Guymer RH, Edwards TL, Sousa DC. Trincão-Marques TM, et al. Among authors: guymer rh. Surv Ophthalmol. 2024 May 10:S0039-6257(24)00049-3. doi: 10.1016/j.survophthal.2024.05.002. Online ahead of print. Surv Ophthalmol. 2024. PMID: 38735629 Free article. Review.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Among authors: guymer r. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
RWC Update: Sometimes Pulling Doesn't Win You the Tug of War; Wet AMD - How Do You Approach Nonexudative Macular Neovascularization; Central Retinal Artery Occlusion With Cilioretinal Sparing.
Sharma A, Wu L, Bloom S, Stanga P, Walinjkar JA, Patel AQ, Sarraf D, Querques G, Sacconi R, Kaiser P, Guymer R, Khanani AM, Mirajkar A, Nagpal M, Rezaei KA. Sharma A, et al. Among authors: guymer r. Ophthalmic Surg Lasers Imaging Retina. 2024 Feb;55(2):66-69. doi: 10.3928/23258160-20240111-01. Epub 2024 Feb 1. Ophthalmic Surg Lasers Imaging Retina. 2024. PMID: 38346151 Free article. No abstract available.
Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice.
Guymer R, Bailey C, Chaikitmongkol V, Chakravarthy U, Chaudhary V, Finger RP, Gallego-Pinazo R, Chuan AKH, Ishida S, Lövestam-Adrian M, Parravano M, Luna Pinto JD, Schmitz-Valckenberg S, Sheth V, Souied EH, Chi GC, Gilberg F, Glittenberg C, Scheidl S, Bengus M. Guymer R, et al. Ophthalmol Sci. 2023 Dec 3;4(3):100442. doi: 10.1016/j.xops.2023.100442. eCollection 2024 May-Jun. Ophthalmol Sci. 2023. PMID: 38304609 Free PMC article.
453 results